Abstract
There seems to be a paucity of agents brought to market for patients with motility or functional digestive disorders, and several agents felt to be truly efficacious have been withdrawn. Treatment options are available particularly if practitioners are willing to pursue alternative prescribing approaches. This article describes mechanisms by which physicians may safely obtain prokinetic agents commonly regarded as inaccessible.
Get full access to this article
View all access options for this article.